| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | BLINATUMOMAB | 3 |
| 2 | ERGOCALCIFEROL | 3 |
| 3 | PREDNISONE | 3 |
| 4 | ANTACID | 2 |
| 5 | CALCIUM CARBONATE | 2 |
| 6 | CLONAZEPAM | 2 |
| 7 | CYTARABINE | 2 |
| 8 | FLUDARABINE PHOSPHATE | 2 |
| 9 | ISONIAZID | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 1 | PEGVISOMANT | 2 | 0.0005 |
| 2 | BLINATUMOMAB | 3 | 0.0003 |
| 3 | TRIAMTERENE | 2 | 0.0003 |
| 4 | DECITABINE | 1 | 0.0002 |
| 5 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE | 1 | 0.0002 |
| 6 | ISONIAZID | 2 | 0.0001 |
| 7 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | DASATINIB | 1 | 0.0001 |
| 9 | PYRAZINAMIDE | 1 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Potassium-sparing Diuretic [EPC] | 2 | 0.0001 |
| 1 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 2 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 3 | Antimycobacterial [EPC] | 2 | 0.0001 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | Human Immunoglobulin G [EPC] | 1 | 0.0000 |
| 6 | Interleukin-17A Antagonist [EPC] | 1 | 0.0000 |
| 7 | Interleukin-12 Antagonist [EPC] | 2 | 0.0000 |
| 8 | Interleukin-23 Antagonist [EPC] | 2 | 0.0000 |
| 9 | Complement Inhibitor [EPC] | 1 | 0.0000 |